Goat Anti-Rabbit IgG H&L (APC)K10867
已验证, 无叠氮钠, Ex:650nm, Em:660nm, 1.0 mg/mL
细分类目：抗体类
抗体
共15,266件商品Goat Anti-Rabbit IgG H&L (Cy5)K10868
已验证, 无叠氮钠, Ex:647nm, Em:665nm
Goat Anti-Rabbit IgG H&L (FITC)K10869
已验证, 无叠氮钠, Ex:498nm, Em:517nm, 1.0 mg/mL
Goat Anti-Rabbit IgG H&L (PE)K10870
已验证, 无叠氮钠, Ex:565nm, Em:575nm, 1.0 mg/mL
Goat Anti-Rabbit IgG H&L (TRITC)K10871
已验证, 无叠氮钠, Ex:557nm, Em:576nm, 1.0 mg/mL
KWAR23 (anti-SIRPg)K10872 · CAS 2243227-60-1
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Roledumab (anti-RHD)K10873 · CAS 1174008-79-7
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Apamistamab (anti-PTPRC)K10874 · CAS 2097132-02-8
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Mogamulizumab (anti-CCR4)K10875 · CAS 1159266-37-1
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Tesnatilimab (anti-NKG2D)K10876 · CAS 2242758-08-1
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Narsoplimab (anti-MASP2)K10877 · CAS 2108782-45-0
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Vopratelimab (anti-ICOS)K10878 · CAS 2039148-04-2
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
LY3076226 (anti-FGFR3)K10879
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Bimagrumab (anti-ACVR2B)K10880 · CAS 1356922-05-8
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Cinpanemab (anti-Alpha-synuclein)K10881 · CAS 2094516-02-4
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Itolizumab (anti-CD6)K10882 · CAS 1116433-11-4
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Ravulizumab (anti-Complement C5)K10883 · CAS 1803171-55-2
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Tesidolumab (anti-Complement C5)K10884 · CAS 1531594-08-7
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Bivatuzumab (anti-CD44v6)K10885 · CAS 214559-60-1
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
SARS CoV-2 N Protein Mouse mAbK10886
无载体, 无叠氮钠, 已验证, 见COA
ARGX-112 (anti-IL-22Ra)K10887
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Nidanilimab (anti-IL-1R3)K10888 · CAS 2171061-85-9
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Lacnotuzumab (anti-M-CSF)K10889 · CAS 1831128-32-5
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
Galiximab (anti-CD80)K10890 · CAS 357613-77-5
无载体, 重组, 低内毒素, 无叠氮钠, 已验证, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
第 37 / 637 页